Combined Therapy for Febrile Ulceronecrotic Mucha-Habermann Disease in Young Children: Case Report and Review

This document represents a case report and literature review published in China regarding Febrile ulceronecrotic Mucha-Habermann disease, also known as Pityriasis Lichenoides Et Varioliformis Acuta. The scope encompasses the management of this condition specifically within preschool-aged children between 3 and 6 years of age.

The authors also report a single case where the patient achieved a cure following treatment in China. The intervention involved a combination of antibiotics, intravenous immunoglobulin, methotrexate, and prednisone. No specific effect sizes or statistical comparisons are provided because the evidence relies on this singular case report alongside the literature review.

Significant limitations exist regarding the strength of this evidence. Follow-up duration was not reported, and safety data including adverse events, serious adverse events, and discontinuations were not reported. The sample size consists of one case report plus a literature review, which restricts generalizability and prevents robust conclusions about efficacy or tolerability.

Clinicians should interpret these findings cautiously given the observational nature and lack of comparative data. While the combination therapy resulted in a cure for the reported patient, the absence of safety reporting and small sample size precludes definitive recommendations for standard care. Further research is needed to establish safety profiles and long-term outcomes for this regimen.